[Adjuvant BCG immunotherapy for breast cancer (T1N0M0, T2N0M0)]. 1984

T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada

The present study was performed to evaluate the effect of BCG immunotherapy for breast cancer (T1n0M0, T2n0M0) in nonrandomized series. During a 5-year follow-up study, patients in the BCG-treated group suffered neither recurrence nor death, while the historical control group had 6 cases of recurrence and 5 cases of disease death. As seen in our series, we concluded that breast cancer patients should be advised to accept adjuvant BCG immunotherapy after mastectomy.

UI MeSH Term Description Entries
D008408 Mastectomy Surgical procedure to remove one or both breasts. Mammectomy,Mammectomies,Mastectomies
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's

Related Publications

T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
October 1986, Surgery,
T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
October 1987, The Surgical clinics of North America,
T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
March 1981, Surgery,
T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
October 1984, Canadian Medical Association journal,
T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
January 1977, Annual review of medicine,
T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
February 2019, Breast (Edinburgh, Scotland),
T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
February 1982, American journal of clinical oncology,
T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
April 1979, Cancer,
T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
January 2024, Hellenic journal of nuclear medicine,
T Sakurai, and K Okada, and H Yokoi, and S Maebeya, and M Juri, and M Takimoto, and O Nishimura, and N Okada
January 1977, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
Copied contents to your clipboard!